Track 10: Cancer Epigenetics 13th International Cancer and Medical Oncology Conference and Exhibition
Track 10: Cancer Epigenetics
13th International Cancer and Medical Oncology Conference and Exhibition
February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE
The 13th International Cancer and Medical Oncology Conference and Exhibition will bring together oncologists, cancer researchers, molecular biologists, clinicians, healthcare innovators, academicians, and industry experts from across the globe to discuss the latest advancements in oncology research and clinical care. One of the highly anticipated sessions of the conference is Track 10: Cancer Epigenetics, focusing on the rapidly evolving role of epigenetic mechanisms in cancer development, diagnosis, and treatment.
Cancer epigenetics has emerged as a transformative area in oncology, offering groundbreaking insights into how gene expression changes influence tumor initiation and progression without altering the DNA sequence itself. This track will highlight innovative research in DNA methylation, histone modification, chromatin remodeling, non-coding RNAs, and epigenetic-targeted therapies that are reshaping precision oncology.
About Track 10: Cancer Epigenetics
Cancer epigenetics studies the heritable and reversible modifications that regulate gene activity in cancer cells. Unlike genetic mutations, epigenetic changes can potentially be reversed, making them highly attractive therapeutic targets.
This scientific track will explore:
Experts attending this track will gain valuable knowledge on how epigenetic alterations contribute to multiple cancer types including breast cancer, lung cancer, colorectal cancer, leukemia, prostate cancer, ovarian cancer, and pediatric malignancies.
Benefits of Attending Track 10
Discover Emerging Research
Participants will learn about the latest discoveries in cancer epigenomics, translational oncology, and targeted therapeutics from leading international experts.
Networking Opportunities
The conference offers a global networking platform connecting researchers, clinicians, pharmaceutical companies, biotechnology innovators, and academic institutions for future collaborations and clinical partnerships.
CME/CPD Accreditation
Attendees can enhance their professional credentials through accredited CME/CPD sessions designed to support continuous medical education and professional advancement.
Publication & Presentation Opportunities
Researchers and scholars will have opportunities to present oral talks, posters, and scientific abstracts while receiving international recognition for their work.
Industry Exposure
Participants can interact with exhibitors, healthcare organizations, diagnostic companies, and pharmaceutical leaders showcasing innovative oncology technologies and solutions.
Scientific Importance of Cancer Epigenetics
Epigenetics has transformed cancer research by revealing how environmental and cellular factors influence tumor behavior. Advances in epigenetic therapies are creating new treatment strategies that improve patient outcomes and enable precision medicine.
Current epigenetic therapies, including DNA methyltransferase inhibitors and histone deacetylase inhibitors, have already shown promising results in hematologic malignancies and solid tumors. Researchers are now exploring combination therapies integrating immunotherapy, targeted therapy, and epigenetic modulation for enhanced treatment efficacy.
Track 10 will provide an interdisciplinary platform where scientists and clinicians can discuss novel biomarkers, therapeutic targets, and future directions in cancer epigenetics.
About the Conference
The 13th International Cancer and Medical Oncology Conference and Exhibition is recognized as a premier international oncology forum that promotes scientific exchange, innovation, and multidisciplinary collaboration in cancer care and research.
Conference Highlights
The conference is expected to host over 280+ participants including oncologists, surgeons, pathologists, radiologists, medical researchers, healthcare professionals, and biotechnology companies from around the world.
Conference Venue – Dubai, UAE
The conference will take place at the prestigious Novotel Al Barsha Dubai, strategically located on Sheikh Zayed Road with convenient access to Dubai’s major attractions and transportation facilities.
Dubai provides an ideal international destination for scientific meetings, combining world-class infrastructure, modern hospitality, global connectivity, and cultural diversity. Delegates attending the conference can also explore iconic attractions such as:
Who Should Attend?
Medical Oncologists
Conclusion
Track 10: Cancer Epigenetics promises to be one of the most impactful sessions at the 13th International Cancer and Medical Oncology Conference and Exhibition. As epigenetic science continues to revolutionize cancer diagnostics and therapeutics, this track offers an exceptional opportunity to explore cutting-edge innovations, engage with global experts, and contribute to the future of precision oncology.
Researchers, clinicians, and healthcare professionals attending this track will gain deeper scientific insights, build valuable collaborations, and discover emerging therapeutic possibilities that can transform cancer care worldwide.
Important Links
https://cancer.utilitarianconferences.com/
https://cancer.utilitarianconferences.com/submit-abstract
https://cancer.utilitarianconferences.com/registration
.jpg)
.png)
Comments
Post a Comment